Project ECHO^®: Endocrine Toxicities
with Immune Checkpoint Inhibitors

Telementoring To Manage Immune-related Adverse Events
in Patients Receiving Cancer Immunotherapies

Session 3 — Endocrinology

CME Information or Content Source:

Content Derived from a CME Certified Webinar in November 2022
Event Sponsor(s):

This activity is supported by an educational grant from Bristol Myers Squibb
Event Details:

Program provided by Boston University (BU) and Association of Community Cancer Centers (ACCC)

Date Recorded:

November 15, 2022
Recording Length:

51:49
Topics:

ACCC, Boston University, endocrinology, immunotherapy, irAE, Project ECHO

Speakers

Jocelyn E. Mohs, PharmD, BCOP
Director of Pharmacy
Sanford Medical Center, Fargo
Fargo, ND

Rajeev Sharma, MD
Assistant Professor of Oncology & Medicine
Division of Endocrinology
Roswell Park Comprehensive Cancer Center
Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, NY

Learning Objectives

At the end of this educational program, participants should be able to:

Apply evidence-based practices for the monitoring and management of immune-related adverse events (irAE) in patients receiving cancer immunotherapies
Improve coordination and communication with non-oncology specialists and with patients/caregivers to manage irAE in patients receiving cancer immunotherapies
Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies

Click here to learn about remaining Project ECHO sessions or to view other available recordings.